Sign inGet started

De Rubertis Francesco

Insider CIK 1601521 · VSAR Director · NERV Director, 10% owner · CNTA Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
CNTA Centessa Pharmaceuticals p D To issuer2026-06-242026-06-244,398,519— $00SEC↗
CNTA Centessa Pharmaceuticals p D To issuer2026-06-242026-06-2455,677— $00SEC↗
CNTA Centessa Pharmaceuticals p D To issuer2026-06-242026-06-243,936,970— $00SEC↗
CNTA Centessa Pharmaceuticals p D To issuer2026-06-242026-06-2493,526— $00SEC↗
CNTA Centessa Pharmaceuticals p D To issuer2026-06-242026-06-2411,197,303— $00SEC↗
CNTA Centessa Pharmaceuticals p D To issuer2026-06-242026-06-24281,162— $00SEC↗
CNTA Centessa Pharmaceuticals p J Other2022-03-212022-03-231,794,211— $011,197,303SEC↗
CNTA Centessa Pharmaceuticals p J Other2022-03-212022-03-2345,054— $0281,162SEC↗
CNTA Centessa Pharmaceuticals p P Buy2021-12-022021-12-06796$12.82 $10.2K93,526SEC↗
CNTA Centessa Pharmaceuticals p P Buy2021-12-022021-12-0633,530$12.82 $429.9K3,936,970SEC↗
CNTA Centessa Pharmaceuticals p P Buy2021-12-012021-12-021,399$12.62 $17.7K92,730SEC↗
CNTA Centessa Pharmaceuticals p P Buy2021-12-012021-12-0258,905$12.62 $743.4K3,903,440SEC↗
CNTA Centessa Pharmaceuticals p P Buy2021-11-302021-12-0235,992$11.62 $418.2K3,844,535SEC↗
CNTA Centessa Pharmaceuticals p P Buy2021-11-302021-12-02855$11.62 $9.9K91,331SEC↗
CNTA Centessa Pharmaceuticals p P Buy2021-11-292021-11-3055,391$11.70 $648.1K3,808,543SEC↗
CNTA Centessa Pharmaceuticals p P Buy2021-11-292021-11-301,315$11.70 $15.4K90,476SEC↗
CNTA Centessa Pharmaceuticals p P Buy2021-11-262021-11-3011,543$11.34 $130.9K3,753,152SEC↗
CNTA Centessa Pharmaceuticals p P Buy2021-11-262021-11-30274$11.34 $3.1K89,161SEC↗
CNTA Centessa Pharmaceuticals p C Conversion deriv2021-06-022021-06-0444,828— $00SEC↗
CNTA Centessa Pharmaceuticals p C Conversion deriv2021-06-022021-06-041,886,990— $00SEC↗
CNTA Centessa Pharmaceuticals p P Buy2021-06-022021-06-0413,923$20.00 $278.5K88,887SEC↗
CNTA Centessa Pharmaceuticals p P Buy2021-06-022021-06-04586,077$20.00 $11.72M3,741,609SEC↗
CNTA Centessa Pharmaceuticals p C Conversion2021-06-022021-06-0444,828— $074,964SEC↗
CNTA Centessa Pharmaceuticals p C Conversion2021-06-022021-06-041,886,990— $03,155,532SEC↗
CNTA Centessa Pharmaceuticals p A Award deriv2021-01-292021-06-0444,828$11.00 $493.1K44,828SEC↗
CNTA Centessa Pharmaceuticals p A Award deriv2021-01-292021-06-041,886,990$11.00 $20.76M1,886,990SEC↗
NERV Minerva Neurosciences, Inc X Exercise deriv2016-12-122016-12-14202,634— $00SEC↗
NERV Minerva Neurosciences, Inc X Exercise2016-12-122016-12-14202,634$5.77 $1.17M4,690,906SEC↗
NERV Minerva Neurosciences, Inc S Sale2016-08-102016-08-121,000,000$10.00 $10.00M4,488,272SEC↗
NERV Minerva Neurosciences, Inc P Buy deriv2015-03-182015-03-20202,634$0.13 $26.3K202,634SEC↗
NERV Minerva Neurosciences, Inc P Buy2015-03-182015-03-20202,634$4.81 $974.7K5,488,272SEC↗
NERV Minerva Neurosciences, Inc C Conversion deriv2014-07-072014-07-0961,922$6.00 $371.5K0SEC↗
NERV Minerva Neurosciences, Inc C Conversion deriv2014-07-072014-07-09114,077$6.00 $684.5K0SEC↗
NERV Minerva Neurosciences, Inc C Conversion2014-07-072014-07-09114,077$6.00 $684.5K3,602,883SEC↗
NERV Minerva Neurosciences, Inc C Conversion2014-07-072014-07-0961,922$6.00 $371.5K3,664,805SEC↗
NERV Minerva Neurosciences, Inc P Buy2014-07-072014-07-091,287,500$6.00 $7.72M4,952,305SEC↗
NERV Minerva Neurosciences, Inc P Buy2014-07-072014-07-09333,333$6.00 $2.00M5,285,638SEC↗
VSAR Versartis, Inc. A Award deriv2014-03-202014-03-2435,000— $035,000SEC↗